Liraglutide-bolus vs Glargine-bolus Therapy in Overweight/Obese Type 2 Diabetes Patients (LiraGooD)
Clinical trial NCT03087032 · RECRUITING
Trial details
- NCT number
- NCT03087032
- Sponsor
- The First Affiliated Hospital of Xiamen University
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-10
- Primary completion
- 2025-01-15
- Enrollment
- 164
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.